Literature DB >> 19057261

Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer.

William D Travis1, Elisabeth Brambilla, Ramon Rami-Porta, Eric Vallières, Masahiro Tsuboi, Valerie Rusch, Peter Goldstraw.   

Abstract

OBJECTIVE: To define the anatomic extent of visceral pleural invasion (VPI) and to assess whether elastic stains are useful to determine VPI in lung cancer. The elastic layer of the visceral pleura is not mentioned in the current International Union Against Cancer or American Joint Committee on Cancer staging documents.
METHODS: A Pub Med search (www.pubmed.gov) of the National Library of Medicine was made for all articles published between 1970 and 2007 in humans under the search terms lung cancer and pleural invasion. These were reviewed for data regarding the pathologic classification of extent of pleural invasion including the use of elastic stains in this assessment.
RESULTS: Six articles that addressed reported survival data using elastic stains to assess for VPI were reviewed. These articles defined P0 (T1) as lack of pleural invasion beyond the elastic layer, P1 (T2) as invasion beyond the elastic layer, P2 (T2) as invasion to the surface of the visceral pleura and P3 (T3) as invasion of the parietal pleura. In five studies, survival was shown to be significantly worse for VPI defined as P1 or P2 compared with P0.
CONCLUSIONS: Based on the currently available data, we propose that the next tumor, node, metastasis (TNM) revision by International Union Against Cancer and American Joint Committee on Cancer define VPI as invasion beyond the elastic layer (PL1) including invasion to the visceral pleural surface (PL2). The abbreviation PL for pleura is recommended rather than P to avoid confusion with the existing use of p (pathologic) TNM in distinction from c (clinical) TNM. We also recommend that elastic stains be used in cases when the distinction between PL0 and PL1 is not clear based on evaluation of hematoxylin and eosin sections.

Entities:  

Mesh:

Year:  2008        PMID: 19057261     DOI: 10.1097/JTO.0b013e31818e0d9f

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  56 in total

1.  Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.

Authors:  Jun-ichi Nitadori; Adam J Bograd; Kyuichi Kadota; Camelia S Sima; Nabil P Rizk; Eduardo A Morales; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  J Natl Cancer Inst       Date:  2013-08-07       Impact factor: 13.506

2.  Predictors of pathological non-invasive lung cancer with pure-solid appearance on computed tomography to identify possible candidates for sublobar resection.

Authors:  Aritoshi Hattori; Tatsuo Maeyashiki; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-04-22       Impact factor: 2.549

3.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

4.  Surgical results and staging of non-small cell lung cancer with interlobar pleural invasion.

Authors:  Ryu Kanzaki; Naoki Ikeda; Eiji Okura; Naoto Kitahara; Yasushi Shintani; Akira Okimura; Kunimitsu Kawahara; Mitsunori Ohta
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-14

Review 5.  Lung cancer staging: an overview of the new staging system and implications for radiographic clinical staging.

Authors:  Joshua Carson; David J Finley
Journal:  Semin Roentgenol       Date:  2011-07       Impact factor: 0.800

6.  Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.

Authors:  Jun-Ichi Nitadori; Christos Colovos; Kyuichi Kadota; Camelia S Sima; Inderpal S Sarkaria; Nabil P Rizk; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

Review 7.  Lung cancer staging: clinical and radiologic perspectives.

Authors:  Sophie Chheang; Kathleen Brown
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

8.  CT diagnosis of pleural and stromal invasion in malignant subpleural pure ground-glass nodules: an exploratory study.

Authors:  Qing Zhao; Jian-Wei Wang; Lin Yang; Li-Yan Xue; Wen-Wen Lu
Journal:  Eur Radiol       Date:  2018-06-25       Impact factor: 5.315

9.  Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.

Authors:  Ramón Rami-Porta; Hisao Asamura; Peter Goldstraw
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.

Authors:  Juan J Fibla; Stephen D Cassivi; Alessandro Brunelli; Paul A Decker; Mark S Allen; Gail E Darling; Rodney J Landreneau; Joe B Putnam
Journal:  Lung Cancer       Date:  2012-10-03       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.